A randomized double‐blind placebo‐controlled crossover pilot study: Acute effects of the enzyme α‐galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients-Reference-Cited by-同舟云学术

A randomized double‐blind placebo‐controlled crossover pilot study: Acute effects of the enzyme α‐galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients

Published:2021-02-22 Issue:7 Volume:33 Page:
ISSN:1350-1925
Container-title:Neurogastroenterology & Motility
language:en
Short-container-title:Neurogastroenterology & Motility

Author:

Böhn Lena¹,Törnblom Hans¹^ORCID,Van Oudenhove Lukas²^ORCID,Simrén Magnus¹³^ORCID,Störsrud Stine¹^ORCID

Affiliation:

1. Department of Molecular and Clinical Medicine Institute of Medicine Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

2. Translational Research Center for Gastrointestinal Disorders (TARGID) Department of Chronic Diseases, Metabolism, and Ageing (CHROMETA) University of Leuven Leuven Belgium

3. Center for Functional GI and Motility Disorders University of North Carolina Chapel Hill North Carolina USA

Funder

Marianne and Marcus Wallenberg Foundation

Publisher

Wiley

Subject

Gastroenterology,Endocrine and Autonomic Systems,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nmo.14094

Reference43 articles.

1. Functional Bowel Disorders

2. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review